Oaktree Acquisition Corp. III Life Sciences
Price Action
Technical Summary
WEAKENINGOaktree Acquisition Corp. III Life Sciences is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 56), indicating performance broadly in line with the market. Earnings growth of 2957% provides fundamental context to the price action. Investors should exercise caution due to high volatility (294% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.82 | +2.68% | ABOVE |
| 50 SMA | $0.80 | +5.36% | ABOVE |
| 100 SMA | $— | — | |
| 150 SMA | $— | — | |
| 200 SMA | $— | — |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is OACCW in an uptrend right now?
OACCW has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is OACCW overbought or oversold?
OACCW's RSI (14) is 51. The stock is in neutral territory, neither overbought nor oversold.
Is OACCW outperforming the market?
OACCW has a Relative Strength (RS) Rating of 56 out of 99. OACCW is performing about average compared to the market.
Where is OACCW in its 52-week range?
OACCW is trading at $0.84, which is 45% of its 52-week high ($1.89) and 25% above its 52-week low ($0.50).
How volatile is OACCW?
OACCW has a Beta of N/A and 52-week volatility of 294%. It moves roughly in line with the overall market.